Clinical Trial

Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated August 18, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the efficacy and safety of a synbiotic formula (BLHK03) in alleviating chemotherapy-induced alopecia (CIA) in breast cancer patients and the compositional and functional changes in the gut microbiome of breast cancer patients undergoing chemotherapy and treatment with BLHK03.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-15.
Status change: Not Yet Recruiting → Recruiting 2024-09-11
Trial Details
NCT Number NCT06560385
Lead Sponsor GenieBiome Limited
Conditions Breast Cancer, Hair Loss
Enrollment 40 participants
Start Date 2024-09-11
Primary Completion 2025-08-18 (estimated)
Study Completion 2026-08-18 (estimated)
Updated on ClinicalTrials.gov 2024-09-19